Navigation Links
CryoLife Begins Distribution of Blood-Clotting Agent PerClot® in Europe
Date:10/25/2010

ATLANTA, Oct. 25 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it has begun European distribution of PerClot®, a novel polysaccharide hemostatic agent used to control bleeding during surgical procedures or following traumatic injuries.

"PerClot is an exciting technology platform that has seen success in Europe already, and we are pleased to begin offering this product in France," stated Steven G. Anderson, CryoLife president and chief executive officer.  "Our international and largely unrestricted distribution agreement allows us to address a very broad range of medical specialties in the growing hemostatic agent market.  We look forward to expanding distribution within the European Union and many other markets around the world in the coming months."

The European hemostatic market is estimated to be $279 million in 2010 growing to approximately $430 million in 2014.(1)

On September 28, 2010, CryoLife entered into a worldwide distribution agreement and a manufacturing agreement with Starch Medical Inc. (SMI) of San Jose, California for PerClot, a unique, absorbable powder hemostat that has CE Mark designation allowing commercial distribution into the European Community and other markets.  PerClot is indicated for use in surgical procedures, including cardiac, vascular, orthopedic, spinal, neurological, gynecological, ENT and trauma surgery as an adjunct hemostat when control of bleeding from capillary, venous, or arteriolar vessels by pressure, ligature, and other conventional means is either ineffective or impractical. 

CryoLife plans to file an Investigational Device Exemption (IDE) with the United States Food and Drug Administration (FDA) to begin clinical trials for the purpose of obtaining Pre-Market Approva
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CryoLife Announces Release Date and Teleconference Call Details for 2010 Third Quarter Financial Results
2. CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive
3. CryoLife Enters into Worldwide Distribution and Manufacturing Agreements with Starch Medical for Novel Hemostatic Agent
4. CryoLife Provides Initial 2010 Financial Guidance
5. CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference
6. CryoLife to Present at Upcoming Investor Conferences in New York
7. CryoLife Reports Record Quarterly Revenues of $28.2 Million
8. CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R)
9. CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
10. BiondVax Begins Phase IIa Study for Universal Flu Vaccine
11. LIG Assets, Inc. Begins Distribution and Marketing of Unique CPAP Mask Cleaner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... 2014 Companies that supply Durable Medical ... contact consumers directly about purchasing such supplies even ... The American Osteopathic Association,s House of Delegates voted ... companies that supply Durable Medical Equipment unless such ... physician and the patient. Typically ...
(Date:7/21/2014)... , July 21, 2014 ... Research titled, "Global biosimilars/follow-on-biologics market (types, applications and ... Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... biosimilars market would reach $35 billion by 2020 ... penetration with clearer regulatory pathways in developed markets ...
(Date:7/21/2014)... , July 21, 2014  PowerVision, Inc., ... fluid-based accommodating intraocular lens, today announced that ... and Law Chair of Ophthalmology, and Professor of ... the company,s Scientific Advisory Board. ... the American Academy of Ophthalmology Lifetime Achievement award, ...
Breaking Medicine Technology:American Osteopathic Association Calls for Eliminating Unsolicited Requests to Purchase Medical Equipment 2Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020 2Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020 3Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020 4PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 2PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 3PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 4
... American Scientific Resources, Incorporated (OTCQB: ASFX) today announced ... containing results for the quarter ending March 31, ... review the entire 10-Q filing. (Logo: ... also like to direct investors to its corporate ...
... ANN ARBOR, Mich., May 24, 2011 ... long-term mechanical ventilation often require extensive additional care, ... A new study led by University ... chronic conditions who require long-term mechanical ventilation have ...
Cached Medicine Technology:American Scientific Resources, Inc. Announces Quarterly Results 2U-M Study: Children Dependent on Long-Term Mechanical Ventilation Require Longer, More Expensive Hospital Care 2U-M Study: Children Dependent on Long-Term Mechanical Ventilation Require Longer, More Expensive Hospital Care 3
(Date:7/22/2014)... (PRWEB) July 22, 2014 Industry-leading health ... announce the release of Specialty Pharmacy Trends and ... book that provides a comprehensive overview of the current ... includes management strategies and tactics for:, , ... cost and utilization concerns — including details of coinsurance ...
(Date:7/22/2014)... 2014 To help offset the typical ... Training Institute of Miami is reducing the cost ... model Brief Strategic Family Therapy™. To implement evidence-based ... variety of funding sources, but those opportunities seem to ... we want to help relieve somehow,” said the model ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Getting breast implants ... be completely optional or due to medical necessity. Either way, ... how to prepare for it, says Robert Kraft, MD, Plastic ... breast implant removal surgeries are performed each year in the ... But 70 percent of those procedures stem from three main ...
(Date:7/22/2014)... The hair transplant experts at WeGrowHair.com / ... laser therapy and robotic assisted hair transplantation to ... suffering from hair loss. Alongside their unique Multi-Unit ... Extraction (FUE) procedures via ARTAS – the world’s ... their doctors use advanced digital mapping to more ...
(Date:7/21/2014)... cancer cells could boost the effectiveness of chemotherapy to ... new study reports. , Scientists at The Institute of ... engineered version of the virus used to vaccinate against ... isolated limb perfusion chemotherapy given directly to blood ... alternative to amputation was more effective in rats ...
Breaking Medicine News(10 mins):Health News:Latest Edition of Annual Book Provides Comprehensive Overview of the Specialty Pharmacy Arena 2Health News:FTTIM Makes Brief Strategic Family Therapy Training a Little More Affordable 2Health News:FTTIM Makes Brief Strategic Family Therapy Training a Little More Affordable 3Health News:Is Breast Implant Removal Right for You? Plastic Surgeon Dr. Robert Kraft With Advanced Dermatology, PC Explains Breast Implant Removal and Offers Tips On Procedure 2Health News:Is Breast Implant Removal Right for You? Plastic Surgeon Dr. Robert Kraft With Advanced Dermatology, PC Explains Breast Implant Removal and Offers Tips On Procedure 3Health News:WeGrowHair.com/PAI Medical Group Introduces Robotic Assisted Laser Therapy to Treat Hair Loss 2Health News:Viral therapy could boost limb-saving cancer treatment 2Health News:Viral therapy could boost limb-saving cancer treatment 3
... sorafenib helps reverse disease resistance to anti-hormonal therapy ... drug sorafenib may help "re-sensitize" certain breast cancer ... Center researchers say. , Women with estrogen-receptor or ... cancers often take anti-hormonal medicines, such as aromatase ...
... hormone-receptor positive, metastatic breast cancer may take medications for ... when the tumor becomes resistant to anti-hormonal drugs, treatment ... presented today at the 2008 ASCO Breast Cancer Symposiummay ... treatment approach can "re-sensitize" the tumor, allowing anti-hormonal drugs ...
... York Fashion Week,s Annual Destination to Feature VelaShape. , ... ... http://www.americanlaser.com [American Laser Centers __title__ American Laser], the largest ... the U.S., announces sponsorship of the STYLE360 show during New York ...
... samples provided to physicians by pharmaceutical companies could actually ... according to a study done by researchers at Wake ... retrospective study looked at the prescribing habits of more ... in the months immediately before and after the closing ...
... 3, 2008In a case-control study, the presence of measles ... autism and GI disturbances than in children with only ... were unrelated to MMR vaccine timing. Study findings ... Science on September 4 ( http://dx.plos.org/10.1371/journal.pone.0003140 ). , ...
... Experts develop sequence of instructions they say could help doctors ... safety experts say that almost all kids who are allergic ... set of standard precautions. , Reporting in the September ... by the Johns Hopkins Children,s Center put forth a step-by-step ...
Cached Medicine News:Health News:Drug Re-Sensitizes Breast Tumors to Treatment 2Health News:1 step back ... 2 steps forward 2Health News:American Laser Centers Sponsors STYLE360 to Share the Skinny on Body Shaping 2Health News:Free drug samples may end up costing uninsured more 2Health News:Free drug samples may end up costing uninsured more 3Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 3Health News:Even Kids With Known Allergies Can Be Safely Vaccinated 2
An intermediate set providing a greater range of telescopes than the starter set....
Significantly more compact and tidier in overall looks yet retain many of the excellent features of the more comprehensive Haag type systems., ,Filters include Cobalt blue; green (red free); neut...
... up to 20 tilting ... in the vertical, horizontal ... the option to offset ... transillumination., ,Filters include Cobalt ...
With a high lens and filter range this ophthalmoscope is ideal for the Primary Care Specialist...
Medicine Products: